Related Experiment Videos
Gastrinoma: advances in localization and treatment
1University of California at San Francisco; San Francisco Veterans Affairs Medical Center, San Francisco, California, USA.
Surgical Oncology Clinics of North America
|September 12, 1998
Summary
Gastrinomas are tumors that cause excess stomach acid. Imaging and surgery are key for diagnosis, treatment, and improving survival in patients with gastrinoma, especially those with liver metastases.
Area of Science:
- Endocrinology
- Surgical Oncology
- Medical Imaging
Background:
- Gastrinomas secrete gastrin, leading to gastric acid hypersecretion.
- Symptoms are manageable with antisecretory medications.
- Primary tumors are in the pancreas or duodenum, with 60% metastasizing.
Purpose of the Study:
- To outline the clinical presentation and management of gastrinomas.
- To emphasize the prognostic significance of liver metastases.
- To highlight the role of diagnostic imaging and surgical intervention.
Main Methods:
- Review of clinical data and treatment outcomes for gastrinoma patients.
- Utilizing somatostatin receptor scintigraphy for disease staging.
- Surgical resection as a primary treatment modality.
Main Results:
- Liver metastases are linked to reduced patient survival.
- Localization studies are crucial for assessing disease extent.
- Surgery offers potential for cure or prolonged survival.
Conclusions:
- Effective management of gastrinomas involves accurate localization and surgical intervention.
- Early detection and treatment of liver metastases are critical for improving outcomes.
- Multidisciplinary approach is essential for optimizing patient survival and quality of life.